http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114794088-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0284 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2022-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114794088-B |
| titleOfInvention | Human pluripotent stem cell cryopreservation solution and its application |
| abstract | The present invention provides a human pluripotent stem cell cryopreservation solution, comprising a basal cell culture medium, a cryoprotectant and a signal pathway inhibitor composition, the signal pathway inhibitor composition comprising CHIR-99021, ID-8 and Y- 27632, and human pluripotent stem cell cryopreservation does not contain any protein components. The human pluripotent stem cell cryopreservation solution of the present invention, through the synergistic effect of three signaling pathway inhibitors, can recover the cryopreserved cells without containing protein components, and has a higher cell viability rate after the recovery. In addition, the human pluripotent stem cell cryopreservation solution of the present invention does not require programmed cooling during cryopreservation, which is more rapid and convenient. The quality of the human pluripotent stem cell cryopreservation solution of the invention is well studied, the product performance is high, the cost is low, and it is suitable for different culture media. |
| priorityDate | 2022-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.